Gemtesa 75 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GB1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,721
Award facts
- Contract value 100% obligated
- $35,720.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $35,720.85 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order is performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (formerly operating as AmerisourceBergen), is a major pharmaceutical distributor serving federal medical procurement needs across the Department of Defense and military healthcare systems.
This delivery order is issued under AmerisourceBergen's comprehensive Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including medications across multiple therapeutic domains, vaccines, and specialized medical supplies. The contract demonstrates the contractor's capability to meet federal procurement requirements through competitive award processes and efficient fulfillment of essential pharmaceutical commodities required by military treatment facilities and veterans' healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F4GB1?
SPE2DR26F4GB1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4GB1 worth?
The government has obligated $35,721 on SPE2DR26F4GB1.
Is contract SPE2DR26F4GB1 an order under another contract?
Yes. SPE2DR26F4GB1 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GB1 competed?
The extent of competition for SPE2DR26F4GB1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award